[
  {
    "ts": null,
    "headline": "CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise",
    "summary": "Charles River tops Q4 earnings and revenue estimates as margins expand, but shares dip, and organic growth declines across all segments.",
    "url": "https://finnhub.io/api/news?id=60126da493ec37a130308eb8ea41716b3db14aeeae942a4958cbcd9ec19c5c6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771422900,
      "headline": "CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise",
      "id": 139136773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Charles River tops Q4 earnings and revenue estimates as margins expand, but shares dip, and organic growth declines across all segments.",
      "url": "https://finnhub.io/api/news?id=60126da493ec37a130308eb8ea41716b3db14aeeae942a4958cbcd9ec19c5c6d"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Inc (NYSE:CAH) Shows Strong Growth and Technical Momentum",
    "summary": "Cardinal Health (CAH) exemplifies a growth-momentum strategy, combining accelerating earnings with a strong technical breakout setup for potential upside.",
    "url": "https://finnhub.io/api/news?id=e1de7f3797c1c6b60c1930c3ea20a576503b96750c20fe5aa707d6c7ae1c5bda",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771413658,
      "headline": "Cardinal Health Inc (NYSE:CAH) Shows Strong Growth and Technical Momentum",
      "id": 139132334,
      "image": "https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp",
      "related": "CAH",
      "source": "ChartMill",
      "summary": "Cardinal Health (CAH) exemplifies a growth-momentum strategy, combining accelerating earnings with a strong technical breakout setup for potential upside.",
      "url": "https://finnhub.io/api/news?id=e1de7f3797c1c6b60c1930c3ea20a576503b96750c20fe5aa707d6c7ae1c5bda"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights include Boot Barn, Brinker International, Tapestry and Cardinal Health",
    "summary": "Boot Barn, Brinker International, Tapestry and Cardinal Health have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=8e071da86d8790c0d504f8da878ed26cd7c2960aa24ebf92914d9d38baf5b27b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771405680,
      "headline": "Zacks.com featured highlights include Boot Barn, Brinker International, Tapestry and Cardinal Health",
      "id": 139132756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Boot Barn, Brinker International, Tapestry and Cardinal Health have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=8e071da86d8790c0d504f8da878ed26cd7c2960aa24ebf92914d9d38baf5b27b"
    }
  },
  {
    "ts": null,
    "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
    "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.",
    "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771404877,
      "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
      "id": 139137337,
      "image": "https://image.cnbcfm.com/api/v1/image/108111981-17412749682025-03-06t152858z_1041948067_rc2r7da7wjpm_rtrmadp_0_usa-trump-fda.jpeg?v=1741274989&w=1920&h=1080",
      "related": "CAH",
      "source": "CNBC",
      "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year. ",
      "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0"
    }
  }
]